Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation of Optos OCT in Patients with Retinal Pathologies

NCT06846151 is registered in ClinicalTrials.gov with Optos, PLC as lead sponsor.

NCT NCT06846151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06846151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation of Optos OCT in Patients with Retinal Pathologies
Lead sponsor
Optos, PLC
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 31, 2025
Completion date
January 31, 2026
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

amd - age-related macular degeneration, control patients, diabetic retinopathy, retinitis pigmentosa (rp)